跳至主要内容
临床试验/IRCT2014041217234N1
IRCT2014041217234N1已完成2 期

Comparing Effectiveness of combination of magnesium oxide and potassium citrate with potassium citrate in children with urolithiasis

Vice chancellor for research, Mashhad University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 14 years(—)
性别
All

入选标准

  • All children:
  • 1.Under 15 years of age with sonographic diagnosis of stone.
  • 2.With stones greater than 2 mm diameter; Microlithiasis below 2 mm due to the possible technical errors and less clinical value will be ignored.
  • 3.Who completed informed consent form.
  • Exclusion criteria:
  • 1.Presence of side effects (such as gastritis, gastrointestinal complications due to potassium citrate, sluggishness, lethargy, muscle weakness and diarrhea due to magnesium which drug would be discontinued in this case)
  • 2.Comorbidities which influence tubular secretion such as renal tubular acidosis, pyelonephritis and obstructive uropathy.
  • 3.Not referring in order to sonography and laboratory tests
  • 4.Diagnosed cases who are under medication therapy
  • 5.Over 15 years old age
  • 6.Stones with 2 mm diameter or less
  • 7.Patients need treatment other than conventional therapies such as patients who need hydrochlorothiazide or cystinuria patients who need penicillamine.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Mashhad University of Medical Sciences

相似试验